A Moulignier1, A Moulonguet, G Pialoux
1Fondation Adolphe de Rothschild, Service de Neurologie, Paris, France. amoulignier@fo-rothschild.fr
This study examined six patients with HIV who developed symptoms similar to ALS, a neurological disorder that affects motor neurons. The patients had low immune cell counts and showed signs of muscle weakness that resembled ALS. The researchers used specific criteria to classify the severity of the condition and ruled out other causes. The patients responded well to antiretroviral therapy, which suggests that HIV may be directly involved in causing these symptoms. The findings indicate that some motor neuron diseases in people with HIV are not random but may be caused by the virus itself. This could help doctors better diagnose and treat neurological complications in HIV patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Prior research has shown that HIV infection can lead to various neurological complications, including motor neuron dysfunction. However, the specific link between HIV and an ALS-like presentation remains unclear. Established knowledge includes the role of HIV in causing immune-mediated and neurotoxic effects. No prior work had resolved whether motor neuron disease in HIV is coincidental or causally linked. This gap motivated a closer examination of patients with both HIV and ALS-like symptoms. The uncertainty around the etiology of these cases led to the need for a descriptive study. The lack of diagnostic clarity in overlapping conditions like ALS and HIV-related neuropathy created a need for better classification. The absence of a clear treatment response in similar cases suggested a need for further investigation. Understanding the connection between HIV and motor neuron disease could improve diagnostic accuracy and therapeutic approaches.
Purpose Of The Study:
The main outcome was that six HIV-positive patients with low CD4+ counts developed motor weakness resembling ALS, which improved with antiretroviral therapy.
Patients were classified using the El Escorial criteria into definite, probable, or possible ALS categories based on clinical and diagnostic features.
EMG was used to assess motor neuron disease characteristics and rule out multifocal conduction block, which is not seen in these cases.
Antiretroviral therapy showed a positive response in patients with HIV-related ALS-like disorder, suggesting a causal link between HIV and the condition.
The aim of this study was to describe the clinical features, treatment, and outcomes of patients with HIV-1-associated ALS-like disorder. The specific problem addressed was the lack of clarity regarding the relationship between HIV infection and motor neuron disease. The motivation stemmed from the observation of patients with both HIV and neurological symptoms resembling ALS. The goal was to determine if these cases were coincidental or pathologically linked. The researchers sought to identify patterns in clinical presentation and response to treatment. By applying the El Escorial criteria, they aimed to classify the certainty of the diagnosis in these patients. The study also aimed to rule out alternative causes of motor weakness in the context of HIV. The ultimate purpose was to contribute to the understanding of HIV-related neurological complications.
Main Methods:
The study reviewed patients with HIV infection who presented with neurological symptoms over a 13-year period. The authors used the El Escorial criteria to categorize cases as definite, probable, or possible ALS. Clinical features were assessed alongside EMG, CSF, serum analyses, and imaging. Virological studies were also conducted to evaluate HIV status and progression. Patients were selected based on immunodepression and motor weakness mimicking ALS. The mean CD4+ cell count and age were recorded for each patient. EMG findings were analyzed to confirm motor neuron disease characteristics. The absence of multifocal conduction block was noted as a distinguishing feature in these cases.
Main Results:
Six patients with HIV-1 developed distal motor weakness resembling monomelic amyotrophy. The mean CD4+ cell count was 86.2/mm³, and the mean age was 34 years. The weakness progressed subacutely and could be regional or symmetric. EMG findings were consistent with motor neuron disease. Multifocal conduction block was not observed in these patients. Alternative causes were ruled out through comprehensive testing. The disease showed rapid progression but responded positively to antiretroviral therapy. These results suggest a possible etiological link between HIV-1 and ALS-like disorder.
Conclusions:
The authors propose that the association between motor neuron disease and HIV infection is pathogenetically related. The positive response to antiretroviral therapy supports this connection. The rapid progression of the disease in these patients suggests a direct role of HIV in motor neuron dysfunction. The absence of multifocal conduction block differentiates these cases from typical ALS. The study highlights the importance of considering HIV-related complications in neurological presentations. The findings suggest that ALS-like disorder should be recognized as an HIV-related condition. The authors do not claim that this is the only mechanism by which HIV affects motor neurons. The study does not propose new treatment strategies but emphasizes the need for further investigation into the relationship between HIV and motor neuron disease.
The mean CD4+ cell count was 86.2/mm³, indicating significant immunodepression in the study population.
The authors suggest that the association between motor neuron disease and HIV is pathogenetically related, not coincidental.